Factors determining how early adopter physicians use buprenorphine in treatment

Journal of Addiction Medicine

Volumn 1, Issue 4, 2007, Pages 205-212

  Reif, Sharon ^a   Thomas, Cindy Parks ^a   Wallack, Stanley S ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

Adoption; Buprenorphine; Opioids; Physician practice; Substance abuse

Indexed keywords

EID: 79954524692     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31814c3fa8     Document Type: Article

References (29)

1. Substance Abuse and Mental Health Services Administration. The SAMHSA Evaluation of the Impact of the DATA Waiver Program: Summary Report. Available at: http://buprenorphine.samhsa.gov/FOR-FINAL-summaryreport-colorized.pdf. Accessed March 27, 2007.
2. Bickel WK, Stitzer ML, Bigelow GE, et al. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther. 1988;247:47-53.
3. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949-958. (Pubitemid 37064768)
4. Johnson RE, Eissenberg T, Stitzer ML, et al. A placebo-controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995;40:17-25.
5. Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297.
6. Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction. 1998;93:475-486. (Pubitemid 28188067)
7. Mello NK, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science. 1980;207:657-659. (Pubitemid 10099961)
8. O'Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998; 105:100-105. (Pubitemid 28405231)
9. Payte JT, Zweben JE, Martin J. Opioid maintenance treatment. In: Graham AW, Schultz TK, Mayo-Smith MF, et al, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, MD: American Society of Addiction Medicine; 2003:751-766.
10. Saxon AJ, McCarty D. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacol Ther. 2005;108:119-128. (Pubitemid 41377124)
11. Sullivan LE, Chawarski MC, O'Connor PG, et al. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005;79:113-116. (Pubitemid 41557130)
12. Stanton A, McLeod C, Luckey B, et al. Expanding treatment of opioid dependence: Initial physician and patient experiences with the adoption of buprenorphine. Paper presented at: American Society of Addiction Medicine, San Diego, CA; 2006.
13. Center for Substance Abuse Treatment/SAMHSA. TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: Center for Substance Abuse Treatment; 2004.
14. Fiellin DA, Kleber H, Trumble-Hejduk JG, et al. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat. 2004;27:153-159. (Pubitemid 39265427)
15. NIH National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:1936-1943.
16. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) - 2004: National Admissions to Substance Abuse Treatment Services. Available at: http://wwwdasis.samhsa.gov/teds04/tedsad2k4web.pdf. Accessed February 13, 2007.
17. Wesson DR. Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S. J Psychoactive Drugs. 2004;SARC Supplement 2:119-128. (Pubitemid 38856437)
18. Koch AL, Arfken CL, Schuster CR. Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability. Drug Alcohol Depend. 2006;83:274-278.
19. Knudsen HK, Ducharme LJ, Roman PM, et al. Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat. 2005;29:95-106. (Pubitemid 41749339)
20. Knudsen HK, Ducharme LJ, Roman PM. Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. J Subst Abuse Treat. 2006;30:363-373. (Pubitemid 43729149)
21. Cunningham CO, Sohler NL, McCoy K, et al. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Fam Med. 2006;38:336-340. (Pubitemid 43723598)
22. Substance Abuse and Mental Health Services Administration. Detailed Emergency Department Tables From Drug Abuse Warning Network 2002. Available at: http://dawninfo.samhsa.gov/old-dawn/pubs-94-02/edpubs/2002final/. Accessed April 2004.
23. Substance Abuse and Mental Health Services Administration. Buprenorphine Physician & Treatment Locator. Available at: http://buprenorphine.samhsa. gov/bwns-locator/index.html. Accessed June 11, 2007.
24. Gelijns A, Rosenberg N. The dynamics of technological change in medicine. Health Aff. 1994;13:28-46. (Pubitemid 24252112)
25. Thomas CP, Wallack SS, Lee S. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat. 2003;24:1-11. (Pubitemid 36315767)
26. Fiellin DA, O'Connor PG. Office-based treatment of opioid-dependent patients. N Engl J Med. 2002;347:817-823. (Pubitemid 34988341)
27. Auriacombe M, Fatseas M, Dubernet J, et al. French field experience with buprenorphine. Am J Addict. 2004;13(Suppl 1):S17-28. (Pubitemid 38585688)
28. Moatti JP, Souville M, Escaffre N, et al. French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine. Addiction. 1998;93:1567-1575. (Pubitemid 28472997)
29. American Medical Association. Physician Marketplace Report: The Practice Arrangement of Patient Care Physicians, 2001. Available at: http://www.ama-assn. org/ama1/pub/upload/mm/363/pmr-022004.pdf. Accessed March 28, 2007.